Joel Greenblatt acquired 115 Thousand Dexcom shares worth $9.71 Million. That's 0.10% of their equity portfolio (292nd largest holding). The first Dexcom trade was made in Q2 2014. Since then Joel Greenblatt bought shares fourteen more times and sold shares on eleven occasions. The investor's estimated purchase price is $11.7 Million, resulting in a loss of 17%.